logo
AI Icon𝛼SK or Search
ENTITY

Cadrenal Therapeutics (CVKD US)

14
Analysis
Health Care • United States
Cadrenal Therapeutics, Inc. operates as a biotech company. The Company focuses on developing tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease, or ESRD, and atrial fibrillation. Cadrenal Therapeutics serves customers worldwide.
more
Company Event • 07 Nov 2026 05:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 29 Sep 2026 22:15 • Upcoming
Add To Calendar

Lytham Partners Fall 2026 Investor Conference

Company Event • 24 Sep 2026 22:00 • Latest

AGM 2026

Company Event • 12 Sep 2026 20:00 • Upcoming
Add To Calendar

Investor presentation

Company Event • 11 Sep 2026 19:00 • Upcoming
Add To Calendar

H.C. Wainwright 28th Annual Global Investment Conference

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x